DINA IRWIN: Open Payments
NPI 1033890918 · SIOUX CITY, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$320 in 18 payments from 9 companies in 2025. Trend: 2023 $732 · 2024 $925 · 2025 $320
Food & beverage: $320
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 4 | $67 |
| Collegium Pharmaceutical, Inc. | 3 | $48 |
| BioMarin Pharmaceutical Inc. | 2 | $39 |
| SANOFI PASTEUR INC. | 2 | $38 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| ABBVIE INC. | 2 | $29 |
| Neurelis, Inc. | 1 | $26 |
| Novo Nordisk Inc | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $14 |
Products named: Qelbree, Jornay PM, VOXZOGO 1.2mg, BEYFORTUS, VRAYLAR, VALTOCO, Wegovy, PENMENVY.
Industry payments across IA — which companies pay providers there.
